Capital Stock (Tables)

6 Months Ended

Sep. 30, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Share-Based Compensation Expense

The Company recognized the following share-based compensation expense during the three and six months ended September 30, 2024 and 2023:

 

	Three Months Ended				Six Months Ended
	September 30,				September 30,
	2024		2023		2024		2023
	(Amounts in millions)
Compensation Expense:
Stock options	$	0.2	$	0.5	$	0.4	$	0.9
Restricted share units and other share-based compensation	8.2		12.9		16.3		20.3
Share appreciation rights	0.2		0.1		0.3		0.2
Total Lionsgate Studios employee share-based compensation expense	8.6		13.5		17.0		21.4
Corporate allocation of share-based compensation	6.7		3.9		10.9		7.6
	15.3		17.4		27.9		29.0
Impact of accelerated vesting on equity awards(1)	4.6		—		4.6		0.5
Total share-based compensation expense	$	19.9	$	17.4	$	32.5	$	29.5

___________________

(1)Represents the impact of the acceleration of vesting schedules for equity awards pursuant to certain severance arrangements prior to the Separation.

Share-based compensation expense, by expense category, consisted of the following:

	Three Months Ended				Six Months Ended
	September 30,				September 30,
	2024		2023		2024		2023
	(Amounts in millions)
Share-Based Compensation Expense:
General and administration	$	15.3	$	17.4	$	27.9	$	29.0
Restructuring and other	4.6		—		4.6		0.5
	$	19.9	$	17.4	$	32.5	$	29.5

Schedule of Stock Option, SARs, Restricted Stock and Restricted Share Unit Activity

The following table sets forth the stock option, share appreciation rights (“SARs”), restricted stock and restricted share unit activity at Lionsgate for grants related directly to the Company employees and Lionsgate corporate and shared service employees during the six months ended September 30, 2024:

	Stock Options and SARs							Restricted Stock and Restricted Share Units
	Lions Gate Class A Voting Shares			Lions Gate Class B Non-Voting Shares				Lions Gate Class A Voting Shares				Lions Gate Class B Non-Voting Shares
	Number of Shares	Weighted-Average Exercise Price		Number of Shares		Weighted-Average Exercise Price		Number of Shares		Weighted-Average Grant-Date Fair Value		Number of Shares	Weighted-Average Grant-Date Fair Value
	(Number of shares in millions)
Outstanding at March 31, 2024	2.4	$	22.96	17.1		$	13.92	0.1		$	9.27	9.8	$	8.93
Granted	—	—		—		—		—		—		7.8	$	7.99
Options exercised or restricted stock or RSUs vested	—	—		—	(1)	$	7.13	—	(1)	$	11.45	(5.7)	$	8.79
Forfeited or expired	(0.1)	$	20.26	(2.1)		$	14.86	—		—		(0.2)	$	9.35
Outstanding at September 30, 2024	2.3	$	23.10	15.0		$	13.80	0.1		$	8.98	11.7	$	8.21

_____________________

(1)Represents less than 0.1 million shares.